Briefings: Boston Scientific Recall, Nerve Stimulation for Sleep Apnea, Overactive Bladder, More

News from around the neurotech industry including Boston Scientific’s recall of Infinion CX lead, results from a hypoglossal nerve stimulation system trial, neural implants that work without batteries, vaginally-inserted, wireless neuromodulation device, cranioplasty implant and BCI connections receive FDA clearance, new US VP of Neuromodulation for Abbott, and more.
